What's happening
This bill requires the Department of Health to analyze prescription monitoring data for inappropriate controlled substance prescribing and report findings to relevant authorities.
Why it matters
Targets Risky Prescribing. By explicitly requiring analysis for "inappropriate prescribing of controlled substances," the bill aims to more proactively catch and address risky or illegal prescription practices, which can help curb opioid abuse and other prescription drug problems.
Enhances Accountability. The requirement for detailed records about what information is shared, with whom, and confirmation of their authority, adds a new layer of oversight—potentially reducing data misuse and ensuring follow-up by the right parties.
Supports Public Health and Safety. Early detection and reporting of questionable prescribing patterns could help protect patients from harm and prevent the escalation of prescription drug misuse into broader public health crises.
Strengthens Regulatory Response. By clarifying the department’s role in data analysis and reporting, the bill could lead to more systematic investigations and responses by health authorities, regulatory boards, or law enforcement, improving the overall monitoring system.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Track Prescription Data Better
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Monitor Prescription Data for Misuse
In Senate Committee · Health · Sponsor Michelle Hinchey
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
873
2023-2024 Regular Sessions
IN ASSEMBLY
January 11, 2023
Introduced by M. of A. L. ROSENTHAL -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to department analysis of the prescription monitoring program registry
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 7 of section 3343-a of the public health law, as added by section 2 of part A of chapter 447 of the laws of 2012, is amended to read as follows:
7. Department analysis of data. The department shall periodically analyze data contained in the prescription monitoring program registry to identify information that indicates that a violation of law or breach of professional standards may have occurred, including the inappropriate prescribing of controlled substances and, as warranted, provide any relevant information to appropriate entities as permitted under section thirty-three hundred seventy-one of this article. The department shall keep a record of the information provided, including, but not limited to, the specific information provided and the agency to which such information was provided, including the name and title of the person to whom such information was provided and an attestation from such person that he or she has authority to receive such information.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD01245-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.